Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
15.61
+0.14 (0.90%)
At close: Apr 2, 2026, 4:00 PM EDT
15.75
+0.14 (0.90%)
After-hours: Apr 2, 2026, 7:03 PM EDT
Aurinia Pharmaceuticals Market Cap
Aurinia Pharmaceuticals has a market cap or net worth of $2.08 billion as of April 2, 2026. Its market cap has increased by 80.57% in one year.
Market Cap
2.08B
Enterprise Value
1.75B
1-Year Change
80.57%
Ranking
Category
Stock Price
$15.61
Market Cap Chart
Since September 3, 2014, Aurinia Pharmaceuticals's market cap has increased from $125.50M to $2.08B, an increase of 1,553.93%. That is a compound annual growth rate of 27.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 2.08B | -1.29% |
| Dec 31, 2025 | 2.10B | 63.56% |
| Dec 31, 2024 | 1.29B | -0.41% |
| Dec 29, 2023 | 1.29B | 110.29% |
| Dec 30, 2022 | 613.90M | -79.30% |
| Dec 31, 2021 | 2.97B | 69.58% |
| Dec 31, 2020 | 1.75B | -8.45% |
| Dec 31, 2019 | 1.91B | 233.25% |
| Dec 31, 2018 | 573.20M | 50.68% |
| Dec 29, 2017 | 380.40M | 366.75% |
| Dec 30, 2016 | 81.50M | 3.69% |
| Dec 31, 2015 | 78.60M | -31.17% |
| Dec 31, 2014 | 114.20M | -9.00% |
| Sep 3, 2014 | 125.50M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mineralys Therapeutics | 2.22B |
| Syndax Pharmaceuticals | 2.22B |
| Day One Biopharmaceuticals | 2.22B |
| Nektar Therapeutics | 2.21B |
| Ultragenyx Pharmaceutical | 2.20B |
| ADMA Biologics | 2.19B |
| Tyra Biosciences | 2.13B |
| Agios Pharmaceuticals | 2.06B |